A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This is a Phase 3 study to evaluate the efficacy, safety and long-term safety of the topical administration of FMX-101, 4% minocycline foam for the treatment of moderate-to-severe acne vulgaris.
Epistemonikos ID: 0fd73cba3a18fc25129f0aa1be8a30d3435a242e
First added on: May 17, 2024